top of page
Profile
Join date: Aug 6, 2020
Posts
Feb 28, 2024 ∙ 1 min
Basilea research report
We published a research report today, highlighting that FY’23 has been a year of excellent execution, both financially and strategically....
152
0
Oct 19, 2023 ∙ 1 min
Basilea antifungal acquistion
This morning’s announcement that Basilea has acquired a clinical-stage novel antifungal highlights the company’s ability to find and...
138
0
Oct 2, 2023 ∙ 2 min
FDA accepts ceftobiprole's NDA
The US FDA has accepted the New Drug Application (NDA) for Basilea's antibiotic ceftobiprole and set 3 April 2024 as the Prescription...
91
0
Andrew Keith
Admin
More actions
bottom of page